Vasco Rx Specialty Pharmacy Revenue and Competitors
Estimated Revenue & Valuation
- Vasco Rx Specialty Pharmacy's estimated annual revenue is currently $4.8M per year.
- Vasco Rx Specialty Pharmacy's estimated revenue per employee is $201,000
Employee Data
- Vasco Rx Specialty Pharmacy has 24 Employees.
- Vasco Rx Specialty Pharmacy grew their employee count by -17% last year.
Vasco Rx Specialty Pharmacy's People
Name | Title | Email/Phone |
---|---|---|
1 | Customer Care Manager | Reveal Email/Phone |
2 | Jr Staff Accountant | Reveal Email/Phone |
Vasco Rx Specialty Pharmacy Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.3M | 111 | 8% | N/A | N/A |
#2 | $17.7M | 88 | -19% | N/A | N/A |
#3 | $6.6M | 33 | -8% | N/A | N/A |
#4 | $29.1M | 145 | 48% | N/A | N/A |
#5 | $1.2M | 6 | -50% | N/A | N/A |
#6 | $2.2M | 11 | 10% | N/A | N/A |
#7 | $4.8M | 24 | -17% | N/A | N/A |
#8 | $34.8M | 173 | 5% | N/A | N/A |
#9 | $46.2M | 230 | 5% | N/A | N/A |
#10 | $3.2M | 16 | -11% | N/A | N/A |
What Is Vasco Rx Specialty Pharmacy?
Welcome to Vasco Rx Specialty Pharmacy An established pharmacy providing quality custom compounded and specialty pharmaceuticals to patients and physicians nationwide for over 20 years. Our specialists combine individual formulation techniques with modern medical knowledge and state of the art technology to provide a product developed especially for you. Here at Vasco Rx Specialty Pharmacy, we are committed to the highest standards of excellence within our areas of pharmaceutical practice. We have included various resources on this site to assist you, from products to information.
keywords:N/AN/A
Total Funding
24
Number of Employees
$4.8M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 24 | N/A | N/A |
#2 | $4.2M | 24 | N/A | N/A |
#3 | $4.2M | 24 | -14% | N/A |
#4 | $4.1M | 24 | -17% | N/A |
#5 | $2.5M | 24 | -78% | N/A |